Table 2 Adverse events (n = 18)
Treatment group 1 (n = 6) | Treatment group 2 (n = 6) | Control group (n = 6) | Total (N = 18) | |||||
|---|---|---|---|---|---|---|---|---|
Cases (n, %) | Events | Cases (n, %) | Events | Cases (n, %) | Events | Cases (n, %) | Events | |
All events | 4 (66.7) | 4 | 1 (16.7) | 1 | 2 (33.3) | 2 | 7 (38.9) | 7 |
Serious events | 0 (0) | 0 | 0 (0) | 0 | 0 (0) | 0 | 0 (0) | 0 |
Leukocytopenia | 1 (16.7) | 1 | 1 (16.7) | 1 | 0 (0) | 0 | 2 (11.1) | 2 |
Grade 1 | 1 (16.7) | 1 | 0 (0) | 0 | 0 (0) | 0 | 1 (5.6) | 1 |
Grade 2 | 0 (0) | 0 | 1 (16.7) | 1 | 0 (0) | 0 | 1 (5.6) | 1 |
Anemia | 3 (50.0) | 3 | 0 (0) | 0 | 2 (33.3) | 2 | 5 (27.8) | 5 |
Grade 1 | 3 (50.0) | 3 | 0 (0) | 0 | 2 (33.3) | 2 | 5 (27.8) | 5 |